Submitted by Anonymous (not verified) on 30 October 2023 - 11:12
Human medicines European public assessment report (EPAR): Elebrato Ellipta, fluticasone furoate,umeclidinium,vilanterol, Pulmonary Disease, Chronic Obstructive, Date of authorisation: 15/11/2017, Revision: 12, Status: Authorised
Source: